plemental Figure S1 , available online at http://atvb.ahajournals.org). Consistent with previous reports of SM22␣ knockout mice, our SM22␣-CreKI heterozygous and homozygous mice were fertile and appeared phenotypically normal.
To determine the temporospatial patterns of Cre-mediated recombination in SM22␣-CreKI mice, we crossed the homozygous SM22␣-CreKI mice with the reporter mice Gt(Rosa)26Sor (The Jackson Laboratory, Bar Harbor, Me; cat. 003309). As shown in the Figure, A, we found that the Cre expression in a heterozygous mouse is sufficient to induce homologous recombination at loxP sites and thus to remove the loxP-flanked STOP signal between the lacZ gene and the Gt(Rosa)26Sor promoter, which leads to ␤-galactosidase (␤-gal) activities. We observed ␤-gal-positive staining in almost all adult SMCs that comprise the medial layer of all large and small arteries and veins, including the arterial circle of Willis, aorta, femoral arteries and veins, the pulmonary artery, small arteries in skeletal muscles, and coronary arteries (Figure, A) . The Cre-mediated recombination in vascular SMCs occurs in all of the arteries and veins we examined (Figure, A; online supplement S2). Consistent with the expression pattern of endogenous SM22␣, ␤-gal-positive staining in the visceral SMCs, including the bladder and gastrointestinal tract in adult mice is observed at high efficiency (Figure, A; online supplement S2). In addition, ␤-gal activity is also found in cardiomyocytes (Figure, A) . However, we found no ␤-gal-positive staining in other tissues such as brain, liver, and skeletal muscle cells.
Distinct from the endogenous SM22␣ expression, the SM22␣-CreKI mice failed to exhibit specific ␤-gal activities in SMCs at all embryonic stages examined, ranging from embryonic day 9 to embryonic day 16.5 (online supplement S3). We detected ␤-gal activities in SMCs and the cardiac myocytes in newborn pups right after birth (day 1).
We also bred SM22␣-CreKI mice with another reporter mouse model, Gt(Rosa)26Sor-green fluorescent protein (GFP; The Jackson Laboratory, Cat#: 004077) that contains an enhanced GFP (eGFP) gene inserted into the Gt(Rosa)26Sor locus. Consistent with the ␤-gal staining pattern, eGFP is expressed higher in the aorta, lower in the heart, but not in skeletal muscle and the brain by Western blot analyses ( Figure 1B) .
These results show that we generated an SM22␣-CreKI mouse line that exhibits SMC-targeted Cre recombinase activities in all arteries, veins, visceral organs, and in cardiac myocytes in adults. This mouse line will be a useful addition to the diverse tools used to study the complicated smooth muscle and cardiac gene function in vivo in adult mice and to establish animal models for cardiovascular diseases.
Jifeng Zhang
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